Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06456294 · ClinicalTrials.gov registry record · NA
Evaluation of a Medication Health Center to Promote Opioid Safety
A NA study of Overdose, sponsored by Kaiser Permanente.
- Active
- Registry status
- NA
- Development phase
- 14
- Enrollment target
- 1
- Study location
NCT06456294: Active NA study of Overdose, sponsored by Kaiser Permanente.
NCT06456294 is a NA study of Overdose that is active but no longer recruiting, run by Kaiser Permanente. The registered enrollment target is 14 participants, below the 265-participant average among 13 other Overdose trials with a reported enrollment target (95% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06456294, a NA study of Overdose, is active but no longer recruiting, sponsored by Kaiser Permanente.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 14 participants
- Enrollment target
- 1
- Study location
Study Summary
This study will assess the impact of an opioid safety clinic intervention for patients prescribed chronic opioid therapy. Outcomes are visits to the clinic, naloxone dispensings, Prescription Drug Monitoring reviews, and Urine Drug Screens conducted
Conditions Studied
Interventions
- BEHAVIORAL MHC Outreach Intervention
Study Locations (1)
Colorado
- Kaiser Permanente Colorado - Aurora
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 14 participants |
| Start Date | 2022-06-15 |
| Est. Completion | 2025-01-01 |
| Phase | NA |
What the registry record for NCT06456294 still lists
NCT06456294 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 14 participants, a relatively small participant target, below the 265-participant average among 13 other Overdose trials with a reported enrollment target (95% lower).
The record links to 1 condition, with Overdose appearing as the primary indexed condition, and to 1 intervention - of which MHC Outreach Intervention is the first listed.
NCT06456294 reports a single indexed study location in Colorado.
Frequently Asked Questions
What is clinical trial NCT06456294 about?
NCT06456294 is a clinical study titled "Evaluation of a Medication Health Center to Promote Opioid Safety". This study will assess the impact of an opioid safety clinic intervention for patients prescribed chronic opioid therapy. Outcomes are visits to the clinic, naloxone dispensings, Prescription Drug Monitoring reviews, and Urine Drug Screens conducted
What is the current status of trial NCT06456294?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 14 participants. The study started on 2022-06-15. Estimated completion is 2025-01-01.
What conditions does trial NCT06456294 study?
This clinical trial studies the following conditions: Overdose.
What interventions are being tested in trial NCT06456294?
The interventions under investigation include: MHC Outreach Intervention (BEHAVIORAL).
Who is sponsoring clinical trial NCT06456294?
This trial is sponsored by Kaiser Permanente, which has 294 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06456294 being conducted?
This trial has 1 study location across Colorado. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Overdose
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06456294's enrollment target sits among peer trials
14 14th of 13 the lowest of 13 other Overdose trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Overdose trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Community-based Education, Navigation, and Support Intervention for Military Veterans
RECRUITING · NA
-
A Universal Primary Care Based Intervention to Reduce Youth Overdose Risk
RECRUITING · NA
-
The Impact of a Web-Based Naloxone Intervention Under Standing Orders to Patients Prescribed Chronic Opioid Therapy
ACTIVE NOT RECRUITING · NA
-
The Ganchero Intervention for Migrant People Who Inject Drugs From Puerto Rico in New York City
ACTIVE NOT RECRUITING · NA
-
Improving Access to Naloxone to Prevent Opioid Overdose Deaths (SAIA-Naloxone)
ACTIVE NOT RECRUITING · NA
-
Pharmacist-Led Interventions to Increase Access to Medications for Opioid Use Disorders (PLI-MOUD)
ACTIVE NOT RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02523092 · 14 participants · Phase 4
Use of CXCL9 as a Biomarker of Acthar Efficacy
- NCT04263285 · 14 participants · NA
Treatment of Depression Post-SCI
- NCT04743271 · 14 participants · NA
Food and Circadian Timing
- NCT05065671 · 14 participants · Phase 1
Microbiome Derived Metabolism and Pharmacokinetics
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT06358040 · started 2026-10 · NA
Opioid Dispenser for Microdiscectomy/Laminectomy